Vitaspring Biomedical annual shares outstanding
2019
2020
2021
2022
2023
2025
2026
Vitaspring Biomedical Shares Outstanding History (VSBC)
Vitaspring Biomedical reported 207.0M shares outstanding at the end of fiscal 2026.
View full Vitaspring Biomedical company overviewVitaspring Biomedical annual shares outstanding history
| Fiscal year | Period ended | Shares outstanding | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-01-31 | 207.0M | 0 | 0.00% |
| 2025 | 2025-01-31 | 207.0M | 55.0M | +36.14% |
| 2023 | 2023-01-31 | 152.1M | 33.5M | +28.23% |
| 2022 | 2022-01-31 | 118.6M | −91.1M | −43.44% |
| 2021 | 2021-01-31 | 209.7M | 198.8M | +1823.22% |
| 2020 | 2020-01-31 | 10.9M | 0 | 0.00% |
| 2019 | 2019-01-31 | 10.9M | — | — |
Vitaspring Biomedical quarterly shares outstanding
Q4.18
Q2.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q4.25
Q4.26
Q1.27
| Fiscal quarter | Period ended | Shares outstanding | Change | YoY change |
|---|---|---|---|---|
| Q1 2027 | 2026-04-30 | 207.0M | 88.4M | +74.57% |
| Q4 2026 | 2026-01-31 | 207.0M | 510,000 | +0.25% |
| Q4 2025 | 2025-01-31 | 207.0M | 510,000 | +0.25% |
| Q4 2023 | 2023-01-31 | 152.1M | −46.3M | −23.34% |
| Q4 2022 | 2022-01-31 | 118.6M | −91.1M | −43.44% |
| Q3 2022 | 2021-10-31 | 206.5M | 152.0M | +278.87% |
| Q2 2022 | 2021-07-31 | 206.5M | 206.5M | +5682894.77% |
| Q1 2022 | 2021-04-30 | 198.4M | 187.5M | +1719.71% |
| Q4 2021 | 2021-01-31 | 209.7M | 198.8M | +1823.22% |
| Q3 2021 | 2020-10-31 | 54.5M | 43.6M | +400.00% |
| Q2 2021 | 2020-07-31 | 3,634 | −10.9M | −99.97% |
| Q1 2021 | 2020-04-30 | 10.9M | 0 | 0.00% |
| Q4 2020 | 2020-01-31 | 10.9M | 0 | 0.00% |
| Q3 2020 | 2019-10-31 | 10.9M | 7.8M | +251.89% |
| Q2 2020 | 2019-07-31 | 10.9M | 7.9M | +263.40% |
| Q1 2020 | 2019-04-30 | 10.9M | — | — |
| Q4 2019 | 2019-01-31 | 10.9M | — | — |
| Q2 2019 | 2018-07-31 | 3.1M | — | — |
| Q4 2018 | 2018-01-31 | 3.0M | — | — |
Vitaspring Biomedical shares outstanding trends
Over the last five reported fiscal years, Vitaspring Biomedical's shares outstanding moved from 10.9M to 207.0M, a change of 196.1M. The latest reported quarter, Q1 2027, shows 207.0M.
About the metric
What shares outstanding means
Shares outstanding is the number of common shares held by investors at a reporting-period end. The count can change because of stock issuance, repurchases, conversions, acquisitions, or stock splits.
Calculation and source
SEC-reported period-end shares
TickerStat displays period-end common shares from SEC filings and adjusts older values to the current share basis when SEC-reported stock-split conversion ratios are available. Values remain as reported when no split ratio is available. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vitaspring Biomedical filings at SEC.gov ↗